BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Neurotech Adds TENS Capability to the Kneehab(R) XP Quadriceps Therapy System for Muscle Rehabilitation and Pain Management


1/17/2012 9:29:38 AM

MINNEAPOLIS, MN--(Marketwire - January 16, 2012) - Neurotech North America has incorporated Transcutaneous Electrical Nerve Stimulation (TENS) capability to its flagship Kneehab XP device to provide pain management capabilities. Kneehab XP is an innovative quadriceps therapy system that is clinically proven to strengthen the quadriceps muscle and improve knee stability. With the addition of TENS, the Kneehab XP is the only conductive garment of its kind to provide both quadriceps strengthening and pain management capabilities in one.

Kneehab, with TENS capability, is cleared by the FDA and is indicated for muscle re-education of the quadriceps, maintaining or increasing range of motion of the knee joint, prevention or retardation of disuse atrophy in the quadriceps, early post-surgical quadriceps strengthening, improved post-surgical knee stability secondary to quadriceps strengthening, and increasing local blood circulation. With the additional TENS programs, the Kneehab is also cleared to provide an adjunctive therapy to reduce the level of pain and pain symptoms associated with osteoarthritis, symptomatic relief of chronic, intractable pain, and an adjunctive treatment in the management of acute, post-surgical or post-traumatic knee pain.

The Kneehab has shown to be an effective adjunct therapy for patients who are pre- and post-surgical for Total Knee Arthroplasty (TKA), sports-related injuries such as Anterior Cruciate Ligament (ACL) repair, degenerative conditions like osteoarthritis, and knee joint conditions like patella femoral pain syndrome (PFPS).

The Kneehab XP system comprises a comfortable, easy-to-use conductive garment and a hand-held controller that delivers patented Multipath™ stimulation to the quadriceps area of the thigh. The system is easy to set up and is comfortable for the patient to wear which results in higher levels of patient compliance than with standard NMES devices. This next-generation design features six programs that deliver Multipath stimulation and three programs delivering TENS.

Multipath, a patented stimulation technology developed by Neurotech, mimics the natural muscle recruitment sequence to maximize fiber contractions and promote rapid recovery from quadriceps atrophy. Multipath is supported by the stimulation being applied to broad sections of the quadriceps region via the conductive garment: more stimulation is applied over a wider area than standard electrotherapy resulting in better muscle recruitment and faster rehabilitation.

Kneehab is only available by prescription. Call Neurotech at 866.453.0578 to find an authorized distributor or visit www.neurotech.us for more information.

Neurotech® is a division of Bio-Medical Research (BMR) Ltd., a worldwide leader providing innovative devices for pain relief and rehabilitative health. Our 40 years of clinical experience and investment in scientific research and development has enabled us to deliver clinically proven solutions that are recommended and prescribed by leading healthcare professionals to help patients accelerate recovery and return to an active lifestyle. (www.neurotech.us)


Contact:
Sara Oxton
Neurotech NA
Office: 952-582-6719
Email: Email Contact



Read at BioSpace.com

Neurotech
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES